Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 1/20 | 0.47 |
| ▸ | ADH1C | P00326 | 1/20 | 0.47 |
| ▸ | ADH1A | P07327 | 1/20 | 0.47 |
| ▸ | ADH7 | P40394 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PRNP | P04156 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9703022 | 0.82 | PSIP1 (0.58) | MAPTPSIP1ALDH1A1TP53HSD17B10 | |
| SCHEMBL2220955 | 0.80 | ALDH1A1 (0.52) | MAPTALDH1A1TP53TDP1KMT2A | |
| SCHEMBL9839095 | 0.78 | ALDH1A1 (0.52) | ALDH1A1HTTLMNAATMSMN1; SMN2 | |
| SCHEMBL8940953 | 0.76 | ALDH1A1 (0.51) | MAPTALDH1A1HTTTDP1KMT2A | |
| SCHEMBL6006902 | 0.75 | ALDH1A1 (0.57) | ADH1BADH1CADH1AADH7ALDH1A1 | |
| SCHEMBL64761 | 0.74 | PSIP1 (0.67) | MAPTPSIP1ALDH1A1TP53HTT | |
| SCHEMBL492985 | 0.73 | MAPT (0.49) | MAPTPSIP1ALDH1A1TP53HTR6 | |
| SCHEMBL11211587 | 0.72 | ALDH1A1 (0.60) | MAPTPSIP1ALDH1A1LMNAMAPK1 | |
| SCHEMBL2616457 | 0.72 | CA2 (0.59) | MAPTPSIP1ALDH1A1TP53HTR6 | |
| SCHEMBL1785001 | 0.72 | PSIP1 (0.52) | MAPTPSIP1ALDH1A1TP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2487175-A1 | PHARMACEUTICAL PRODUCT CONTAINING AROMATIC HETEROCYCLIC COMPOUND | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-20120196854-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-08-02 | — | — | US | disclosed |
| US-5565470-A | HYPOTENSIVE OR ANTIARRHYTHMIA AGENTS, ALSO FOR TREATMENT OF ANGINA OR GLAUCOMA | SANOFI (FR) | 1996-10-15 | — | — | US | disclosed |
| US-5340820-A | Useful for treatment of ocular diseases, angina pectoris, hypertension and arrhythmia | ELF SANOFI (FR) | 1994-08-23 | — | — | US | disclosed |
| EP-0382628-B1 | Aminoalkoxylphenyl derivatives, process for their preparation and compositions containing them | SANOFI ELF (FR) | 1994-05-04 | — | — | EP | disclosed |
| US-5147878-A | Hypotensive, antiarrhythmia agents | SANOFI (FR) | 1992-09-15 | — | — | US | disclosed |
| EP-0242001-B1 | PROCESS FOR THE MANUFACTURE OF N-(SULFONYLMETHYL) FORMAMIDES AND SULFONYLMETHYLISOCYANIDES | ROUSSEL-UCLAF (FR) | 1991-03-06 | — | — | EP | disclosed |
| EP-0382628-A1 | Aminoalkoxylphenyl derivatives, process for their preparation and compositions containing them | ELF SANOFI (FR) | 1990-08-16 | — | — | EP | disclosed |
| EP-0382618-A2 | Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them | SANOFI (FR) | 1990-08-16 | — | — | EP | disclosed |
| US-4922016-A | Process for the preparation of N-(sulfonylmethyl) formamide compounds | GIST-BROCADES N.V. (NL) | 1990-05-01 | — | — | US | disclosed |
| EP-0242001-A1 | Process for the manufacture of n-(sulfonylmethyl) formamides and sulfonylmethylisocyanides | ROUSSEL-UCLAF (FR) | 1987-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196854-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND | CYP2C18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP2B6 | MAPT 2243/4885PSIP1 3147/4885ADH1B 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.